Today, leading crowdfunding platform OurCrowd is sharing the news that their portfolio company Sight Diagnostics is succeeding where Theranos failed.
Read more here.
Today, leading crowdfunding platform OurCrowd is sharing the news that their portfolio company Sight Diagnostics is succeeding where Theranos failed.
Read more here.
![[SaNOtize in Business Wire] SaNOtize Obtains Health Canada Approval to Begin Enrolment for Phase III Trials for COVID-19 Anti-Viral Treatment](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
